DiaMedica Therapeutics Inc. (DMAC) — Insider Trading
Insider trading activity for DiaMedica Therapeutics Inc. sourced from SEC EDGAR Form 4 filings.
Overview
- Total insider trades: 9
- Last trade date: Jun 3, 2026
- Ticker: DMAC
Top Insiders
- Semba Charles Pauling — 1 trades, buy: $0, sell: $0
- Pauls Dietrich John (President & CEO) — 1 trades, buy: $0, sell: $0
- Parsons James T. — 1 trades, buy: $0, sell: $0
- Giuffre Randall Michael — 1 trades, buy: $0, sell: $0
- Krop Julie (Chief Medical Officer) — 1 trades, buy: $0, sell: $0
Recent Trades
| Date | Insider | Ticker / Company | Type | Shares | Value |
|---|---|---|---|---|---|
| Jun 1, 2026 | Kuntz Richard | DMAC DiaMedica Therapeutics Inc. | BUY | 40,412 | N/A |
| Jun 1, 2026 | O'Connor Daniel J. | DMAC DiaMedica Therapeutics Inc. | BUY | 40,412 | N/A |
| Jun 1, 2026 | Lewis Tanya | DMAC DiaMedica Therapeutics Inc. | BUY | 40,412 | N/A |
| Jun 1, 2026 | Kellen Scott | DMAC DiaMedica Therapeutics Inc. | BUY | 162,000 | N/A |
| Jun 1, 2026 | Krop Julie | DMAC DiaMedica Therapeutics Inc. | BUY | 67,500 | N/A |
| Jun 1, 2026 | Giuffre Randall Michael | DMAC DiaMedica Therapeutics Inc. | BUY | 40,412 | N/A |
| Jun 1, 2026 | Parsons James T. | DMAC DiaMedica Therapeutics Inc. | BUY | 51,189 | N/A |
| Jun 1, 2026 | Pauls Dietrich John | DMAC DiaMedica Therapeutics Inc. | BUY | 380,000 | N/A |
| Jun 1, 2026 | Semba Charles Pauling | DMAC DiaMedica Therapeutics Inc. | BUY | 40,412 | N/A |